← Back to feed
corporatemerger acquisition1 source · 6d ago

RPG Life Sciences acquiring Raghava Life Sciences’ API, intermediates business for ₹135 crore

RPG Life Sciences is acquiring the API and intermediates business of Raghava Life Sciences for ₹135 crore.

Affected◉ India◉ IN-TG▪ Actis Generics▪ Hyderabad▪ Raghava Life Sciences◇ Ashok Nair◇ Lohith Ponguleti▪ RPG Active Pharma▪ RPG Life Sciences
⌗ 1 outlet · 1 origin · Balanced
India × 1

No Reader read of this story yet.

Perspectives

The story's competing narratives, side by side — grouped by stance, with every outlet's origin and affiliation visible.

Perspective analysis pending — it generates as coverage from more origins arrives.

What to expect

First-order impacts with their likely second-order effects — direction and horizon per node.

Impact analysis pending.

Sources (1)

RPG Life Sciences acquiring Raghava Life Sciences’ API, intermediates business for ₹135 crore — Prism